Showing results (501-510 of 539) with videos related to
Sort By:
Pageof 54
JCI Insight|January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of deathOlivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.Clinical and Experimental Rheumatology|August 30, 2018
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project)Pilar Brito-Zerón, Nihan Acar-Denizli, Wan-Fai Ng, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2017
Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's SyndromeRohan Sharma, Valerie M Harris, Joshua Cavett, et al.Plos One|February 13, 2014
Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk geneYukinori Okada, Dorothee Diogo, Jeffrey D Greenberg, et al.Seminars in Arthritis and Rheumatism|February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generationRachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.Nature Reviews. Rheumatology|June 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren diseaseManuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, et al.Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.Plos Medicine|October 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortiumSigne Hässler, Delphine Bachelet, Julianne Duhaze, et al.Pageof 54